Sunshine Biopharma (SBFM) announced its Board of Directors has formally approved a strategic investment of $5M in Bitcoin (BTC-USD) as a strategic reserve asset. This move aligns with Sunshine Biopharma’s broader strategy to strengthen its financial foundation while advancing its pipeline of generic prescription drugs and proprietary mRNA-based cancer therapies and antiviral drug candidates. The Company’s Bitcoin investment of $5M will be executed over time through a regulated digital asset custodian or, the purchase of an ETF or a proxy stock. The Company plans to increase its holdings of Bitcoin by allocating additional funds as such funds become available in the future.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.